放射治疗设备的印度市场评估:各产品，各用途，各终端用户，各地区，机会，预测(2018年度～2032年度)

印度放射治疗设备市场规模预计将从 2024 财年的 4.1222 亿美元增至 2032 财年的 7.0827 亿美元，并预计从 2025 财年到 2032 财年将以 7.00% 的复合年增长率增长。由于癌症负担的增加、本地製造、技术进步和公私合作伙伴关係，该市场正在不断增长。

由于新癌症患者数量的增加、医疗支出的增加以及政府加强癌症治疗的努力，市场正在扩大。蓬勃发展的经济和快速增长的中产阶级人口促使了对先进医疗技术采用的巨额投资。此外，透过强大的当地能力实现医疗器材生产自给自足的动机是减少对进口的依赖。强而有力的公私伙伴关係促进了先进治疗中心的建立。此外，癌症筛检和早期发现意识的提高也促使对放射治疗服务的需求增加。该国渴望成为全球医疗中心，因此需要部署先进的放射治疗设备，这对于提供优质的癌症治疗和在国际市场上具有竞争力至关重要。

此外，专业癌症中心和放射治疗设施等医疗中心的扩张将增加放射治疗设备的可用性和可近性。例如，2024 年 4 月，新德里哈丁夫人医学院开始使用近距离放射治疗设备治疗第一位癌症患者。这种治疗是为患有某些癌症和其他疾病的患者提供的。更多设施的建立将改善放射治疗服务的可近性，从而增加对患者进一步治疗的放射治疗设备的需求。

本报告提供印度的放射治疗设备市场相关调查分析，提供市场规模与预测，市场动态，主要企业的形势等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 印度的放射治疗设备市场预测(2018年度～2032年度)

• 市场规模的分析与预测
  • 金额
  • 数量
• 市场占有率的分析与预测
  • 各产品
  • 各用途
  • 各终端用户
  • 各地区
  • 市场占有率分析:各企业(金额)(前五名公司和其他 - 2024年度)
• 市场地图分析(2024年度)
  • 各产品
  • 各用途
  • 各终端用户
  • 各地区

第5章 供需分析

第6章 进口和出口的分析

第7章 价值链分析

第8章 波特的五力分析

第9章 大环境分析

第10章 价格分析

第11章 市场动态

• 推动市场要素
• 市场课题

第12章 市场趋势与发展

第13章 法规结构和革新

• 法规当局的认证

第14章 专利形势

第15章 案例研究

第16章 竞争情形

• 市场前五名领导者企业的竞争矩阵
• 前五名公司的SWOT分析
• 主要企业前五名公司的形势
  • Elekta Medical Systems India Pvt. Ltd.
  • Accuray Medical Equipment India Pvt. Ltd.
  • Koninklijke Philips N.V.
  • Ion Beam Applications S.A.
  • Vision RT Ltd.
  • BEBIG Medical GmbH
  • Mitsubishi Electric India Pvt. Ltd.
  • Varian Medical Systems, Inc.
  • Society for Applied Microwave Electronics Engineering & Research
  • Brainlab India Pvt. Ltd.

第17章 策略性推荐

第18章 本公司相关资料，免责声明

India radiotherapy devices market is projected to grow at a CAGR of 7.00% from FY2025 to FY2032, increasing from USD 412.22 million in FY2024 to USD 708.27 million by FY2032. The market for radiotherapy devices in India is growing due to an increase in the cancer burden, indigenous manufacturing, technological advancements, and public-private partnerships.

The Indian radiotherapy devices market is expanding as new cancer cases are growing, healthcare expenditure is rising, and the government is taking initiatives to enhance cancer care. The booming economy and rapidly growing middle-class population in the nation have resulted in huge investments in adopting advanced healthcare technologies. Moreover, the motivation for the achievement of self-sufficiency in the production of medical equipment with strong indigenous capabilities is to reduce the dependence on imports. Strong public-private partnerships are making it easy to establish advanced treatment centers. Also, the increasing awareness of screening and early cancer detection further results in rising demand for radiotherapy services. The country's aspirations to position itself as a global healthcare hub create the need to equip the country with advanced radiotherapy equipment, which would prove indispensable in supplying quality cancer care and placing the country competitively in the international market.

Furthermore, the expansion of healthcare centers, such as specialized centers of cancer and radiation therapy facilities, enhances the availability and accessibility of radiotherapy equipment. For instance, in April 2024, Lady Hardinge Medical College, located in New Delhi, inaugurated and treated its first cancer patient with brachytherapy equipment. This treatment is provided for patients suffering from some kinds of cancers and other diseases. With more facilities being set up, this will increase accessibility to radiotherapy services, hence increasing the demand for radiotherapy devices in further treatment of patients.

Increasing Cancer Burden Influencing India Radiotherapy Devices Market Growth

The rising burden of cancer cases in India is resulting in a higher demand for radiotherapy devices, which, in turn, leads to the expansion of the radiotherapy devices market. The alarming increase in cancer cases in India, which gets worsened by significantly delayed diagnoses resulting in higher mortality rates along with lower recoveries, necessitates raising public awareness and educational awareness among professionals to address this significant issue. Predictive and precision medicine, and integrated AI diagnostics, provide further hope to tackle this issue. The demand for radiotherapy devices is expected to significantly increase as diagnostic methods become more common and affordable. Increasingly systematic screening programs focusing on prevalent cancers, as well as on high-risk individuals, are essential. Risk identification and improvement of data sharing constitute part of the government's digital health initiatives. Collaboration between the public and private sectors is of utmost importance in adequately dealing with the growing burden of cancer. Such interaction will promote demand for better-advanced radiotherapy technologies that improve patient care and outcomes. Public-Private Partnerships (PPPs) have significantly increased access to cancer care in India. For example, Varian Medical Systems, Inc. has partnered with the Central and State Governments to establish radiation therapy centers in public hospitals. The government provides the infrastructure, while private operators supply the equipment and services at agreed-upon prices for the benefit of patients.

Increasing Government Initiatives to Drive the Radiotherapy Devices Market Growth

The government has initiated various schemes and policies to encourage growth in the medical devices market, particularly radiotherapy equipment. The Make in India initiative supports the domestic manufacturing of medical devices, including those used in cancer treatment, to reduce import dependency. Moreover, in the Production Linked Incentive Scheme (PLI) scheme, incentives are proposed for specific cancer care technologies, including advanced radiotherapy technologies.

Such developments allow growth and innovation for the medical industry in India, which, in turn, attracts investments that help research institutions develop technology to increase the adoption of advanced medical devices in health facilities. In this case, with growing awareness about treatments for cancer treatment, more patients will look at the need for advanced therapies, increasing device demand and promoting the Indian radiotherapy devices market progression. For instance, in June 2024, Apollo Cancer Centres partnered with Accuray Medical Equipment India Pvt. Ltd., to introduce India's first Robotic Stereotactic Radiotherapy Program. It will provide advanced training for radiation oncologists, physicists, and technicians in Chennai and Bangalore locations. This program will feature hands-on training and in-depth discussions to enhance local medical education, providing improved cancer care using the Cyberknife system.

Developments in Technology to Propel India Radiotherapy Devices Market Growth

With the increase in cancer cases, there is an emerging demand for advanced technologies in treatment, especially among late-stage cancers that are challenging to treat. The rise in cancer cases in India highlights the market for an advanced and affordable healthcare system covering cancer care so that anyone can easily approach cancer care. Innovations in radiotherapy from key players in the healthcare sector are involved in improving comfort for cancer patients. Many hospitals and medical facilities have embraced these innovations. Advanced treatment techniques used include proton therapy, precision radiation therapies such as intensity-modulated radiation therapy, and image-guided radiation therapy. For instance, in August 2024, Sahyadri Hospitals Private Limited installed the TomoTherapy Radixact X9 system with VitalHold technology. This radiotherapy solution has unfolded new dimensions in treating cancer by providing precision, significantly when tumors are affected by patient movement. It is the first installation in Asia with the system and features Auto Beam Hold, which will cease radiation if the patient moves beyond safe limits. Advanced imaging capabilities significantly improve the detection and accuracy of treatment in tumors, hence elevating patient care.

Hospitals to Hold Substantial Market Share

Hospitals in India account for a relatively more significant share of the radiotherapy devices market due to the increasing patient requirements for cancer treatment, technological advancements, and government initiatives towards healthcare infrastructure development. Their capability to provide comprehensive care invests in modern equipment that enhances the quality of service delivered. This trend accelerates market growth, attracts further investments in innovations, and brings about healthy competition among the manufacturers, which results in better accessibility and affordability of radiotherapy services amongst patients located in various parts of the country. Therefore, hospitals are increasingly installing such advanced radiotherapy devices in their facility to improve patient outcomes. For instance, in April 2024, the Swami Rama Himalayan University (SRHU) Cancer Research Institute (Himalayan Hospital) installed the Halcyon B Linear Accelerator for radiotherapy at the Himalayan Hospital. With cancer cases on a leap and bound in India, this high-end machine will enhance the present treatment portfolio of the patients. Being the first private teaching hospital in Uttarakhand wielding this technology, Himalayan Hospital would ensure the pain of the side effects among its affected patients is not so grueling during treatment and, hence, bring a highly positive change.

Future Market Scenario (FY2025 -FY2032F)

Technologically advanced elements, such as precision radiation therapy, integration of AI for treatment planning, and new technologies like proton therapy, will drive the Indian market for radiotherapy devices. Major companies are stressing cost-effective solutions and are enhancing patient care through personalized treatment approaches. In September 2024, Accuray Medical Equipment India Pvt. Ltd (Accuray) unveiled its CE-marked Accuray Helix system in India. The CT-guided helical radiotherapy system will provide high performance and efficiency, reaching into emerging markets where advanced cancer care, including radiotherapy is often limited to urban areas with fewer facilities such as a linear accelerator.

Key Players Landscape and Outlook

Major players in India radiotherapy devices market are building their presence through partnerships with government hospitals, increasing the distribution outreach, and investing in local manufacturing. It includes improving access to best-in-class cancer treatment and resultant gains to strengthen their competitive position in the market.

In November 2023, Elekta AB (Elekta) received an order worth USD 40 million from Krishna Institute of Medical Sciences (KIMS) in Hyderabad. The order includes cutting-edge equipment like the Elekta Unity MR-Linacs and Leksell Gamma Knife systems, which will enable KIMS to deliver more personalized cancer treatments and enhance the care of their patients while minimizing side effects.

In July 2023, Elekta AB (Elekta) collaborated with GE HealthCare Technologies Inc., intending to scale up accessibility to precise radiation therapy in India. Through this agreement, these companies will ensure that complete systems for imaging and treatment are delivered to hospitals, providing radiation therapy to cancer patients and, hence, improving the care of patients.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Radiotherapy Devices Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. External Beam Radiation Therapy Devices
      • 4.2.1.1.1. Advanced Linear Accelerators
        • 4.2.1.1.1.1. Gamma Knife
        • 4.2.1.1.1.2. Cyberknife
        • 4.2.1.1.1.3. TomoTherapy
        • 4.2.1.1.1.4. MRI LINAC
      • 4.2.1.1.2. Conventional Linear Accelerators
      • 4.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
      • 4.2.1.1.4. Proton Therapy Devices
        • 4.2.1.1.4.1. Cyclotrons
        • 4.2.1.1.4.2. Synchrotron
        • 4.2.1.1.4.3. Synchrocyclotron
    • 4.2.1.2. Internal Beam Radiation Therapy Devices
      • 4.2.1.2.1. Brachytherapy Devices
      • 4.2.1.2.2. Consumables
    • 4.2.1.3. Others
  • 4.2.2. By Application
    • 4.2.2.1. Lung Cancer
    • 4.2.2.2. Breast Cancer
    • 4.2.2.3. Prostate Cancer
    • 4.2.2.4. Head and Neck Cancer
    • 4.2.2.5. Other Applications
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Ambulatory Surgical Centers
    • 4.2.3.3. Cancer Care Centers
  • 4.2.4. By Region
    • 4.2.4.1. North
    • 4.2.4.2. South
    • 4.2.4.3. East
    • 4.2.4.4. West and Central
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 5 Market Players
  • 16.3.1. Elekta Medical Systems India Pvt. Ltd.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 16.3.2. Accuray Medical Equipment India Pvt. Ltd.
  • 16.3.3. Koninklijke Philips N.V.
  • 16.3.4. Ion Beam Applications S.A.
  • 16.3.5. Vision RT Ltd.
  • 16.3.6. BEBIG Medical GmbH
  • 16.3.7. Mitsubishi Electric India Pvt. Ltd.
  • 16.3.8. Varian Medical Systems, Inc.
  • 16.3.9. Society for Applied Microwave Electronics Engineering & Research
  • 16.3.10. Brainlab India Pvt. Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Radiotherapy Devices Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Radiotherapy Devices Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. India Radiotherapy Devices Market Share (%), By Product, FY2018-FY2032F
• Figure 4. India Radiotherapy Devices Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Radiotherapy Devices Market Share (%), By End-user, FY2018-FY2032F
• Figure 6. India Radiotherapy Devices Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024